230 related articles for article (PubMed ID: 35330147)
1. α2-Antiplasmin as a Potential Therapeutic Target for Systemic Sclerosis.
Kanno Y; Shu E
Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330147
[TBL] [Abstract][Full Text] [Related]
2. The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis.
Kanno Y; Shu E; Kanoh H; Seishima M
J Invest Dermatol; 2016 Apr; 136(4):762-769. PubMed ID: 26743600
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.
Kanno Y
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30709025
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice.
Kanno Y; Shu E; Niwa H; Seishima M; Ozaki KI
Mol Biol Rep; 2021 Apr; 48(4):3431-3437. PubMed ID: 33913094
[TBL] [Abstract][Full Text] [Related]
5. α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis.
Kanno Y; Shu E; Kanoh H; Matsuda A; Seishima M
Arthritis Res Ther; 2017 Feb; 19(1):22. PubMed ID: 28159016
[TBL] [Abstract][Full Text] [Related]
6. alpha2-antiplasmin is associated with the progression of fibrosis.
Kanno Y; Kawashita E; Minamida M; Kaneiwa A; Okada K; Ueshima S; Matsuo O; Matsuno H
Am J Pathol; 2010 Jan; 176(1):238-45. PubMed ID: 20008146
[TBL] [Abstract][Full Text] [Related]
7. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
[TBL] [Abstract][Full Text] [Related]
8. Decrease in matrix metalloproteinase‑3 activity in systemic sclerosis fibroblasts causes α2‑antiplasmin and extracellular matrix deposition, and contributes to fibrosis development.
Niwa H; Kanno Y; Shu E; Seishima M
Mol Med Rep; 2020 Oct; 22(4):3001-3007. PubMed ID: 32945390
[TBL] [Abstract][Full Text] [Related]
9. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
Nielsen VG; Ellis TC
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
[TBL] [Abstract][Full Text] [Related]
11. α2-antiplasmin positively regulates endothelial-to-mesenchymal transition and fibrosis progression in diabetic nephropathy.
Kanno Y; Hirota M; Matsuo O; Ozaki KI
Mol Biol Rep; 2022 Jan; 49(1):205-215. PubMed ID: 34709571
[TBL] [Abstract][Full Text] [Related]
12. Alpha2-antiplasmin is a critical regulator of angiotensin II-mediated vascular remodeling.
Hou Y; Okada K; Okamoto C; Ueshima S; Matsuo O
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1257-62. PubMed ID: 18436805
[TBL] [Abstract][Full Text] [Related]
13. The fibrinolysis inhibitor alpha2-antiplasmin in the human cornea.
Ayala A; Warejecka DJ; Vaughan KA; Twining SS; Yue BY
Curr Eye Res; 2005 Dec; 30(12):1097-103. PubMed ID: 16354623
[TBL] [Abstract][Full Text] [Related]
14. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
Wiman B; Lijnen HR; Collen D
Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
[TBL] [Abstract][Full Text] [Related]
15. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
16. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
Mohammed BAB
J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
[TBL] [Abstract][Full Text] [Related]
18. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
Ray MJ; Hales M; Marsh N
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
[TBL] [Abstract][Full Text] [Related]
19. Alpha2-antiplasmin on cardiovascular diseases.
Matsuno H
Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500
[TBL] [Abstract][Full Text] [Related]
20. Identification of glycated and acetylated lysine residues in human α2-antiplasmin.
Bryk AH; Cysewski D; Dadlez M; Undas A
Biochem Biophys Res Commun; 2020 Jan; 521(1):19-23. PubMed ID: 31653347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
